Ikeuchi, Takeshi

Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer’s Disease

Watanabe, Y., Hirao, Y., Kasuga, K., Tokutake, T., Kitamura, K., Niida, S., Ikeuchi, T., Nakamura, K., & Yamamoto, T. (2020) · Dementia and Geriatric Cognitive Disorders Extra

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 38

Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study

Wisch, J. K., McKay, N. S., Boerwinkle, A. H., Kennedy, J., Flores, S., Handen, B. L., Christian, B. T., Head, E., Mapstone, M., Rafii, M. S., et al. (2024) · The Lancet Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 37

Potential Novel Genes for Late-Onset Alzheimer’s Disease in East-Asian Descent Identified by APOE-Stratified Genome-Wide Association Study

Kang, S., Gim, J., Lee, J., Gunasekaran, T. I., Choi, K. Y., Lee, J. J., Seo, E. H., Ko, P.-W., Chung, J. Y., Choi, S.-M., et al. (2021) · Journal of Alzheimer's Disease

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 36

Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia

Llibre-Guerra, J. J., Fernandez, M. V., Joseph-Mathurin, N., Bian, S., Carter, K., Li, Y., Aschenbrenner, A. J., Pottier, C., Sigurdson, W., McDade, E., et al. (2025) · Nature Medicine

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 28

A functional variant of SHARPIN confers increased risk of late-onset Alzheimer’s disease

Asanomi, Y., Shigemizu, D., Akiyama, S., Miyashita, A., Mitsumori, R., Hara, N., Ikeuchi, T., Niida, S., & Ozaki, K. (2022) · Journal of Human Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 19

Consensus meta-analysis of genome-wide association studies for Alzheimer’s disease and related dementias

EADB, Bellenguez, C., Castillo Morales, A., Amin, N., van der Lee, S. J., Muntaner, M., Parveen, K., Küçükali, F., Grenier-Boley, B., Heikkinen, S., et al. (2026) · Nature Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 7

Association of rare APOE missense variants with Alzheimer's disease in the Japanese population

Miyashita, A., Obinata, A., Hara, N., Mitsumori, R., Kaneda, D., Hashizume, Y., Sano, T., Takao, M., Gabdulkhaev, R., Tada, M., et al. (2025) · Journal of Alzheimer’s Disease

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 5

Omics analysis of Alzheimer’s disease stratified by the microglial polygenic effect

Kikuchi, M., Miyashita, A., Hirota, Y., Hara, N., Hasegawa, M., Sakakibara, Y., Sekiya, M., Saito, Y., Murayama, S., Iijima, K. M., et al. (2023) · Alzheimer's & Dementia

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 1

APOE rare missense variants in Japan

Miyashita, A., Hara, N., Obinata, A., Tsukie, T., Hasegawa, M., Kikuchi, M., Kasuga, K., & Ikeuchi, T. (2024) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 0